Immunosuppressive drugs after lung transplantation.
作者信息
Briffa N, Morris R E
出版信息
BMJ. 1998 Mar 7;316(7133):719-20.
Abstract
摘要
相似文献
1
Immunosuppressive drugs after lung transplantation.肺移植后的免疫抑制药物。
BMJ. 1998 Mar 7;316(7133):719-20.
2
Immunosuppressive regimens of tomorrow.未来的免疫抑制方案。
Transplant Proc. 1995 Dec;27(6):2971-3.
3
Maintenance pharmacological immunosuppressive strategies in renal transplantation.肾移植中的维持性药理免疫抑制策略
Postgrad Med J. 1997 Jul;73(861):386-90. doi: 10.1136/pgmj.73.861.386.
4
New immunosuppressive drugs in transplantation.移植领域的新型免疫抑制药物。
Transplant Proc. 1993 Aug;25(4):2681-3.
5
Molecular mechanisms of immunosuppressive chemical agents recently introduced in clinical transplantation protocols.近期临床移植方案中引入的免疫抑制化学药物的分子机制。
Nephrol Dial Transplant. 1997 Oct;12(10):2050-4. doi: 10.1093/ndt/12.10.2050.
6
Clinical and experimental immunosuppression.临床与实验性免疫抑制
Bol Asoc Med P R. 1995 May-Jun;87(5-6):106-8.
7
New immunosuppressive agents for organ transplantation.用于器官移植的新型免疫抑制剂。
Acta Clin Belg. 1997;52(4):199-203. doi: 10.1080/17843286.1997.11718576.
8
[Advances in the fundamentals and therapeutic use of immunosuppressive agents].[免疫抑制剂的基础与治疗应用进展]
Arerugi. 1992 Mar;41(3):381-4.
9
Review of immunosuppression for lung transplantation. Novel drugs, new uses for conventional immunosuppressants, and alternative strategies.肺移植免疫抑制的综述。新型药物、传统免疫抑制剂的新用途及替代策略。
Clin Chest Med. 1997 Jun;18(2):353-66. doi: 10.1016/s0272-5231(05)70384-1.
10
Immunosuppressive approaches to the prevention of graft vascular disease.预防移植物血管疾病的免疫抑制方法。
Transplant Proc. 1998 May;30(3):878-80. doi: 10.1016/s0041-1345(98)00084-0.
引用本文的文献
1
Effects of immune suppression for transplantation on inflammatory colorectal cancer progression.移植免疫抑制对炎症性结直肠癌进展的影响。
Oncogenesis. 2018 Jun 19;7(6):46. doi: 10.1038/s41389-018-0055-5.
2
Exploiting novel molecular targets in gastrointestinal cancers.探索胃肠道癌症中的新型分子靶点。
World J Gastroenterol. 2007 Nov 28;13(44):5845-56. doi: 10.3748/wjg.v13.i44.5845.
本文引用的文献
1
An investigation of the pharmacokinetics, toxicity, and clinical efficacy of Neoral cyclosporin in cystic fibrosis patients.新山地明（Neoral）环孢素在囊性纤维化患者中的药代动力学、毒性及临床疗效研究。
Transplant Proc. 1997 Feb-Mar;29(1-2):599-601. doi: 10.1016/s0041-1345(96)00319-3.
2
Sirolimus: a new agent for clinical renal transplantation.
Transplant Proc. 1997 Feb-Mar;29(1-2):48-50. doi: 10.1016/s0041-1345(96)00008-5.
3
4
Mycophenolate mofetil in renal allograft recipients: a pooled efficacy analysis of three randomized, double-blind, clinical studies in prevention of rejection. The International Mycophenolate Mofetil Renal Transplant Study Groups.霉酚酸酯用于肾移植受者：三项预防排斥反应的随机、双盲临床研究的汇总疗效分析。国际霉酚酸酯肾移植研究组
Transplantation. 1997 Jan 15;63(1):39-47. doi: 10.1097/00007890-199701150-00008.
5
Molecular mechanisms of action of new xenobiotic immunosuppressive drugs: tacrolimus (FK506), sirolimus (rapamycin), mycophenolate mofetil and leflunomide.新型外源性免疫抑制药物的作用分子机制：他克莫司（FK506）、西罗莫司（雷帕霉素）、霉酚酸酯和来氟米特。
Curr Opin Immunol. 1996 Oct;8(5):710-20. doi: 10.1016/s0952-7915(96)80090-2.
6
The International Society for Heart and Lung Transplantation 16th annual meeting and scientific sessions. New York, New York, March 15-18, 1996. Abstracts.国际心肺移植学会第16届年会及科学会议。纽约，1996年3月15日至18日。摘要。
J Heart Lung Transplant. 1996 Jan;15(1 Pt 2):S1-114.
7
Methotrexate can halt the progression of bronchiolitis obliterans syndrome in lung transplant recipients.甲氨蝶呤可阻止肺移植受者闭塞性细支气管炎综合征的进展。
J Heart Lung Transplant. 1996 Sep;15(9):948-54.
8
The Registry of the International Society for Heart and Lung Transplantation: thirteenth official report--1996.国际心肺移植学会注册处：1996年第十三份官方报告。
J Heart Lung Transplant. 1996 Jul;15(7):655-74.
9
Aerosolized cyclosporine in lung recipients with refractory chronic rejection.雾化环孢素用于难治性慢性排斥反应的肺移植受者。
Am J Respir Crit Care Med. 1996 Apr;153(4 Pt 1):1451-5. doi: 10.1164/ajrccm.153.4.8616581.
10
The relative effects of FK506 and cyclosporine on short- and long-term kidney graft survival.FK506和环孢素对肾移植短期和长期存活的相对影响。
Transplantation. 1995 Dec 27;60(12):1384-8. doi: 10.1097/00007890-199560120-00002.
Zotero 插件